(Q33998293)

30 July 2017

1 reference

title

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor (English)

1 reference

30 July 2017

1 reference

12

D Meyer

0 references

J. Evan Sadler

1

object named as

J E Sadler

1 reference

30 July 2017

U Budde

2

1 reference

30 July 2017

J C J Eikenboom

3

1 reference

30 July 2017

E J Favaloro

4

1 reference

30 July 2017

F G H Hill

5

1 reference

30 July 2017

L Holmberg

6

1 reference

30 July 2017

J Ingerslev

7

1 reference

30 July 2017

C A Lee

8

1 reference

30 July 2017

D Lillicrap

9

1 reference

30 July 2017

P M Mannucci

10

1 reference

30 July 2017

C Mazurier

11

1 reference

30 July 2017

D Meyer

12

1 reference

30 July 2017

W L Nichols

13

1 reference

30 July 2017

M Nishino

14

1 reference

30 July 2017

I R Peake

15

1 reference

30 July 2017

F Rodeghiero

16

1 reference

30 July 2017

R Schneppenheim

17

1 reference

30 July 2017

Z M Ruggeri

18

1 reference

30 July 2017

A Srivastava

19

1 reference

30 July 2017

R R Montgomery

20

1 reference

30 July 2017

A B Federici

21

1 reference

30 July 2017

Working Party on von Willebrand Disease Classification

22

1 reference

30 July 2017

2 August 2006

1 reference

Journal of Thrombosis and Haemostasis

30 July 2017

1 reference

30 July 2017

4

1 reference

30 July 2017

2103-2114

1 reference

30 July 2017

10

1 reference

Biochemistry and genetics of von Willebrand factor

30 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Cysteine-mutations in von Willebrand factor associated with increased clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granule-specific and dependent on genetic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

A molecular approach to the classification of von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Genetic heterogeneity of severe von Willebrand disease type III in the German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Laboratory diagnosis of congenital von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

von Willebrand disease: laboratory aspects of diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Genetic determinants of hemostasis phenotypes in Spanish families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Von Willebrand disease type 1: a diagnosis in search of a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Desmopressin (DDAVP) Responsiveness in Children With von Willebrand Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Treatment of von Willebrand's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02146.X

10.1111/J.1538-7836.2006.02146.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference